[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359485-105":59,"doc-detail-359485-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","curcumin-inhibits-glycolysis-via-ep300-in-oral-squamous-cell-carcinoma","Curcumin inhibits glycolysis via EP300 in oral squamous cell carcinoma","","Curcumin, a natural polyphenolic compound, is examined for its ability to suppress glycolysis in oral squamous cell carcinoma (OSCC) with a focus on EP300 as an epigenetic regulator. OSCC cells (UM-SCC-1, HSC-3) and normal oral keratinocytes (HOK) are treated with curcumin at multiple concentrations, followed by assays for proliferation, clonogenic growth, migration, glucose uptake, and lactate production. Curcumin reduces EP300 expression and downregulates PKM2, LDHA, and GLUT1; EP300 overexpression restores glycolytic activity and partially reverses curcumin effects.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/curcumin-inhibits-glycolysis-via-ep300-in-oral-squamous-cell-carcinoma/359485/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/curcumin-inhibits-glycolysis-via-ep300-in-oral-squamous-cell-carcinoma/359485.png","ImageObject",300,407,{"name":92,"@type":93},"Kyle","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main question addressed by this study?","Question",{"text":113,"@type":114},"The study investigates how curcumin affects glycolysis in OSCC cells and whether EP300 is a key mediator of the underlying mechanism.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were glycolytic activity changes measured in OSCC cells?",{"text":118,"@type":114},"Glycolysis was evaluated by measuring glucose uptake and lactate production after curcumin treatment.",{"name":120,"@type":111,"acceptedAnswer":121},"What happens to glycolysis when EP300 is overexpressed during curcumin treatment?",{"text":122,"@type":114},"EP300 overexpression enhances glycolytic activity and increases PKM2, LDHA, and GLUT1 expression, partially reversing curcumin’s inhibitory effects.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},359485,1790322858,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nCurcumin inhibits glycolysis via EP300 in oral squamous cell carcinoma  \nWanrong Tang1,2,3, Chao Zhang1,2,3, Li Han1,2, Haoxuan Fu1,2, Zhouhong Mao1,2, Yongheng Zhang1,2, Ying Liu1,2, Lihua Li1,2 & Jie Yu1,2  \nCurcumin, a natural polyphenolic compound known for its antitumor efficacy, has been shown to modulate glycolytic pathways in various cancers. However, its specific role and underlying mechanism in oral squamous cell carcinoma (OSCC) remain insufficiently explored. This study systematically investigated the impact of curcumin on glycolysis in OSCC cells, with particular focus on EP300, a key epigenetic regulator, as a target of curcumin’s action. Human oral squamous cell carcinoma cell lines (UM-SCC-1 and HSC-3) and normal human oral keratinocytes (HOK) were treated with curcumin at various concentrations. Cell proliferation, clonogenic ability, and migration were assessed using CCK-8, colony formation, and wound-healing assays, respectively. Glycolytic activity was evaluated by measuring glucose uptake and lactate production. An EP300-overexpressing UM-SCC-1 cell line was established via plasmid transfection. Protein-protein interaction (PPI) network analysis through the STRING database identified potential EP300-regulated glycolytic enzymes. Expression levels of EP300 and key glycolytic markers (PKM2, LDHA, GLUT1) were quantified using qRT-PCR and Western blot. Curcumin significantly inhibited proliferation, clonogenic growth, and migration of OSCC cells (UM-SCC-1 and HSC-3) in a concentration-dependent manner. Curcumin treatment markedly reduced glucose uptake and lactate production in OSCC cells, indicating effective suppression of glycolytic activity. At the molecular level, Curcumin downregulated EP300 expression. EP300 overexpression enhanced glycolytic activity and increased the expression of key glycolytic enzymes, including PKM2, LDHA, and GLUT1, and partially reversed the inhibitory effects of curcumin on glycolysis and enzyme expression. Bioinformatic analysis confirmed interactions between EP300 and these glycolytic enzymes. Curcumin suppresses glycolysis in OSCC by modulating EP300 expression and downregulating key glycolytic enzymes such as PKM2, LDHA, and GLUT1. These findings are consistent with curcumin’s potential role as a metabolic modulator in OSCC.  \nOral squamous cell carcinoma (OSCC), the most prevalent malignancy of the head and neck, accounts for approximately 90% of all oral cancers1. Its persistently high incidence and mortality rates pose a significant global health challenge2. Beyond its lethality, OSCC is frequently associated with disfigurement and severe functional impairments, including dysphagia, speech disorders, and loss of taste, all of which substantially diminish patients’ quality of life3,4. These limitations underscore the urgent need for novel therapeutic strategies.  \nNatural compounds have gained increasing attention for their potential in cancer prevention and treatment, with curcumin emerging as one of the most extensively studied candidates due to its pronounced anticancer activity5. Curcumin, a polyphenolic compound derived from the rhizome of Curcuma longa, exhibits a wide range of pharmacological properties, including anti-inflammatory6, antioxidant7, and anticancer effects8. Extensive studies have demonstrated that curcumin can inhibit tumor cell proliferation, invasion, and metastasis by modulating multiple signaling pathways9–11.  \nA defining hallmark of cancer cells is their reprogrammed energy metabolism. Even in the presence of oxygen, tumor cells preferentially convert glucose to lactate through glycolysis, a phenomenon termed the “Warburg effect”12.This metabolic shift not only ensures a continuous supply of energy and biosynthetic intermediates but also contributes to the establishment of a tumor-promoting microenvironment13, 14. Aberrant metabolic reprogramming has been closely lin","cbCaiaGz7AtesVNY","https://ap.wps.com/l/cbCaiaGz7AtesVNY","pdf",3267767,"English","# Introduction\n## Oral squamous cell carcinoma and therapeutic need\n## Curcumin as a cancer metabolic modulator\n## Warburg effect and glycolysis targeting\n# EP300 and its role in tumor metabolism\n## EP300/CBP as an epigenetic regulator\n## Evidence linking EP300 to glycolysis\n# Study aim (curcumin–EP300–glycolysis axis)","[{\"question\":\"What is the main question addressed by this study?\",\"answer\":\"The study investigates how curcumin affects glycolysis in OSCC cells and whether EP300 is a key mediator of the underlying mechanism.\"},{\"question\":\"How were glycolytic activity changes measured in OSCC cells?\",\"answer\":\"Glycolysis was evaluated by measuring glucose uptake and lactate production after curcumin treatment.\"},{\"question\":\"What happens to glycolysis when EP300 is overexpressed during curcumin treatment?\",\"answer\":\"EP300 overexpression enhances glycolytic activity and increases PKM2, LDHA, and GLUT1 expression, partially reversing curcumin’s inhibitory effects.\"}]","Curcumin inhibits glycolysis via EP300 in oral squamous cell carcinoma | PDF",1790137005,25,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4424dba133255827aedd5a8d1e67e4e5.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c9e50878bcad50446afd0b2fb725bcb.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/83f27e9fb1ba852a1e506ef6665b33bc.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c97eac7f4951b00c86b65d16092ac8f8.webp",980,1287]